Scientific data are lacking.
作者信息
Hagmann Sigurd-Gerd
出版信息
Dtsch Arztebl Int. 2013 Mar;110(10):174. doi: 10.3238/arztebl.2013.0174a. Epub 2013 Mar 8.
Abstract
摘要
相似文献
1
Scientific data are lacking.
Dtsch Arztebl Int. 2013 Mar;110(10):174. doi: 10.3238/arztebl.2013.0174a. Epub 2013 Mar 8.
2
Limited range of indications for cannabis.
Dtsch Arztebl Int. 2013 Mar;110(10):174. doi: 10.3238/arztebl.2013.0174b. Epub 2013 Mar 8.
3
In reply.
Dtsch Arztebl Int. 2013 Mar;110(10):175. doi: 10.3238/arztebl.2013.0175. Epub 2013 Mar 8.
4
The therapeutic potential of cannabis and cannabinoids.
Dtsch Arztebl Int. 2012 Jul;109(29-30):495-501. doi: 10.3238/arztebl.2012.0495. Epub 2012 Jul 23.
5
[Cannabis and cannabinoids-easier access, hype and disappointment : What has been confirmed in therapy?].
Internist (Berl). 2019 Mar;60(3):309-314. doi: 10.1007/s00108-019-0556-0.
6
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
JAMA. 2015;313(24):2456-73. doi: 10.1001/jama.2015.6358.
7
The cannabis paradox.
Can Fam Physician. 2018 Feb;64(2):86.
8
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Eur J Pain. 2018 Mar;22(3):440-454. doi: 10.1002/ejp.1147. Epub 2017 Nov 13.
9
Cannabis-based medicinal products: summary of NICE guidance.
BMJ. 2020 Apr 21;369:m1108. doi: 10.1136/bmj.m1108.
10
[Marihuana and cannobinoids as medicaments].
Przegl Lek. 2012;69(10):1095-7.
本文引用的文献
1
The therapeutic potential of cannabis and cannabinoids.
Dtsch Arztebl Int. 2012 Jul;109(29-30):495-501. doi: 10.3238/arztebl.2012.0495. Epub 2012 Jul 23.
Zotero 插件